Compounds > glycyl-glycyl-glycyl-glycine
Page last updated: 2024-08-25

glycyl-glycyl-glycyl-glycine and octaarginine

glycyl-glycyl-glycyl-glycine has been researched along with octaarginine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Baba, M; Sakuma, S; Shigeno, K; Tanishita, S; Tobita, E; Tomono, T; Ukawa, M; Uto, T; Yagi, H; Yoshida, Y1
Baba, M; Miyata, K; Sakuma, S; Tanishita, S; Tobita, E; Tomono, T; Tsujioka, T; Ukawa, M; Uto, T; Yoshida, Y1
Igi, R; Ishizaki, S; Kobayashi, H; Kumagai, H; Miwa, T; Miyata, K; Nonomura, M; Sakuma, S; Tobita, E; Tomono, T; Ukawa, M; Yagi, H1

Other Studies

3 other study(ies) available for glycyl-glycyl-glycyl-glycine and octaarginine

ArticleYear
Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
    Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3

    Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Cross Reactions; Female; Humans; Hyaluronic Acid; Immunity, Humoral; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Mice; Mice, Inbred BALB C; Nasal Mucosa; Oligopeptides; Vaccination

2019
Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses.
    Bioconjugate chemistry, 2019, 12-18, Volume: 30, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Alphainfluenzavirus; Animals; Cross Reactions; Humans; Hyaluronic Acid; Immunoglobulin A; Immunoglobulin G; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mice; Oligopeptides

2019
Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2020, Volume: 154

    Topics: Administration, Intranasal; Animals; Exenatide; Human Growth Hormone; Hyaluronic Acid; Mice; Nasal Absorption; Nasal Mucosa; Octreotide; Oligopeptides; Peptides

2020